000 | 01966 a2200517 4500 | ||
---|---|---|---|
005 | 20250516182729.0 | ||
264 | 0 | _c20140513 | |
008 | 201405s 0 0 eng d | ||
022 | _a1873-2399 | ||
024 | 7 |
_a10.1016/j.exphem.2013.11.006 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKarimiani, Ehsan Ghayoor | |
245 | 0 | 0 |
_aSingle-cell analysis of K562 cells: an imatinib-resistant subpopulation is adherent and has upregulated expression of BCR-ABL mRNA and protein. _h[electronic resource] |
260 |
_bExperimental hematology _cMar 2014 |
||
300 |
_a183-191.e5 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aBenzamides _xpharmacology |
650 | 0 | 4 |
_aCell Adhesion _xdrug effects |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 |
_aFusion Proteins, bcr-abl _xgenetics |
650 | 0 | 4 | _aGene Expression Profiling |
650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImatinib Mesylate |
650 | 0 | 4 | _aIn Situ Hybridization, Fluorescence |
650 | 0 | 4 | _aK562 Cells |
650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xgenetics |
650 | 0 | 4 |
_aMicroRNAs _xgenetics |
650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
650 | 0 | 4 |
_aPiperazines _xpharmacology |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcr _xgenetics |
650 | 0 | 4 |
_aPyrimidines _xpharmacology |
650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
650 | 0 | 4 |
_aSingle-Cell Analysis _xmethods |
650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
700 | 1 | _aMarriage, Fiona | |
700 | 1 | _aMerritt, Anita J | |
700 | 1 | _aBurthem, John | |
700 | 1 | _aByers, Richard John | |
700 | 1 | _aDay, Philip J R | |
773 | 0 |
_tExperimental hematology _gvol. 42 _gno. 3 _gp. 183-191.e5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.exphem.2013.11.006 _zAvailable from publisher's website |
999 |
_c23301823 _d23301823 |